Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial

Isbell, Lisa K; Uibeleisen, Roswitha; Friedl, Alexander; Burger, Elvira; Dopatka, Tatja; Scherer, Florian; Orban, Andras; Lauer, Eliza; Malenica, Natalie; Semenova, Inna; Vreden, Annika; Valk, Elke; Wendler, Julia; Neumaier, Simone; Fricker, Heidi; El Rabih, Abed Al Hadi; Gloggengießer, Cora; Hilbig, Daniela; Bleul, Sabine; Weis, Joachim; Gmehlin, Dennis; Backenstrass, Matthias; Wirtz, Sebastian; Ihorst, Gabriele; Finke, Jürgen; Illerhaus, Gerald; Schorb, Elisabeth

doi:10.1186/s12885-023-11193-7

BMC Cancer

Article metrics
Last updated: Thu, 9 May 2024 6:57:13 Z

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial

Access & Citations

1736

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com